Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Optimizing the Effect of COPD Rehabilitation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2007 by Glostrup University Hospital, Copenhagen.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Ministry of the Interior and Health, Denmark
Information provided by:
Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier:
NCT00419289
First received: January 4, 2007
Last updated: NA
Last verified: January 2007
History: No changes posted

January 4, 2007
January 4, 2007
January 2007
Not Provided
  • Disease specific Quality of Life
  • Work Capacity
Same as current
No Changes Posted
Number of days admitted to hospital
Same as current
Not Provided
Not Provided
 
Optimizing the Effect of COPD Rehabilitation
Rehabilitation of COPD Patients: Can the Effect be Prolonged by Follow-up and Continued Rehabilitation

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme. However, the effect of the programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Patients with Chronic Obstructive Pulmonary Disease (COPD) may benefit from an 8-week pulmonary rehabilitation programme according to guidelines of the Danish Society of Pulmonary Medicine. However, the effect of programme tends to attenuate with time. Patients who complete the programme are randomized to continued rehabilitation follow-up and control follow-up.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Chronic Obstructive Pulmonary Disease
Behavioral: follow-up rehabilitation of participants with COPD
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
120
June 2008
Not Provided

Inclusion Criteria:

  • FEV1 < 60% of expected

Exclusion Criteria:

  • Other severe chronic conditions
Both
Not Provided
No
Contact: Susanne Vest, MD susanne.vest@dadlnet.dk
Contact: Allan Linneberg, MD alli@glostruphosp.kbhamt.dk
Denmark
 
NCT00419289
KA20060179
Not Provided
Not Provided
Glostrup University Hospital, Copenhagen
Ministry of the Interior and Health, Denmark
Principal Investigator: Susanne Vest, MD Glostrup University Hospital, Copenhagen
Glostrup University Hospital, Copenhagen
January 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP